Tomato lycopene prevention of alcoholic fatty liver disease and hepatocellular carcinoma development
Alcoholic liver disease (ALD) is a major cause of morbidity and mortality worldwide. The incidence of hepatocellular carcinoma (HCC) is increasing in the United States, and chronic, excessive alcohol consumption is responsible for 32%–45% of all the liver cancer cases in the United States. Avoidance...
Main Authors: | Camilla P. Stice, Hui Xia, Xiang-Dong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2018-12-01
|
Series: | Chronic Diseases and Translational Medicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2095882X18300665 |
Similar Items
-
Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma: Implications for Lycopene Intervention
by: Blanche C. Ip, et al.
Published: (2013-12-01) -
Risk of Hepatocellular Carcinoma in Patients with Non-alcoholic Fatty Liver Disease
by: Dong Yun Kim, et al.
Published: (2021-07-01) -
The Development of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease
by: Oh Sang Kwon, et al.
Published: (2017-06-01) -
Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese Rats
by: Mariane Róvero Costa, et al.
Published: (2019-08-01) -
Hepatocellular carcinoma and non-alcoholic fatty liver disease: a dangerous liaison
by: R. Nevola, et al.
Published: (2019-05-01)